Ayan Durmus, Cagatay Ak
Department of Medical Biochemistry, Nigde Training and Research Hospital, Nigde, Turkiye.
Department of Medical Biochemistry, Nigde Omer Halisdemir University, School of Medicine, Nigde, Turkiye.
Hepatol Forum. 2023 Sep 20;4(3):108-117. doi: 10.14744/hf.2023.2023.0009. eCollection 2023.
Genes related to the circadian rhythm control various biological processes. The aim of this study was to comprehensively investigate the mutational and mRNA profile of core circadian rhythm genes in hepatocellular cancer (HCC) samples.
In this study, the gene profile of a total of 369 patients with HCC was examined over the data obtained from the cancer genome atlas database through-cBioPortal. The effects of mutations on protein were examined by scoring the Polymorphism Phenotyping v2, Mutation Assessor, and SIFT-databases. While the association of genes with other genes was determined with the GeneMANIA-database, the association of expression levels in the genes with overall survival (OS) was evaluated with the Kaplan-Meier Plot database.
As a result of the analyses, there were a total of 25 mutations. Decreased expression levels of PER1 (1.3e-05), PER3 (p=0.046), and CRY2 (p=1.8e-06) genes were found statistically associated with shorter OS. It was also found that increased expression levels of the PER2 (p=0.045) gene were associated with longer OS, and increased expression levels of the NPAS2 (p=9e-04) gene were associated with shorter OS.
In particular, changes in the PER1, PER2, CRY2, and NPAS2 genes may provide possible molecular targets in chemotherapy and immunotherapy for HCC patients.
与昼夜节律相关的基因控制着各种生物过程。本研究的目的是全面调查肝细胞癌(HCC)样本中核心昼夜节律基因的突变情况和mRNA谱。
在本研究中,通过cBioPortal从癌症基因组图谱数据库获取的数据,检查了总共369例HCC患者的基因谱。通过对多态性表型分析v2、突变评估器和SIFT数据库进行评分,研究突变对蛋白质的影响。使用GeneMANIA数据库确定基因与其他基因的关联,使用Kaplan-Meier Plot数据库评估基因表达水平与总生存期(OS)的关联。
分析结果显示,共有25个突变。发现PER1(1.3e-05)、PER3(p=0.046)和CRY2(p=1.8e-06)基因的表达水平降低与较短的OS在统计学上相关。还发现PER2(p=0.045)基因表达水平升高与较长的OS相关,NPAS2(p=9e-04)基因表达水平升高与较短的OS相关。
特别是,PER1、PER2、CRY2和NPAS2基因的变化可能为HCC患者的化疗和免疫治疗提供可能的分子靶点。